These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7741390)

  • 1. [Interview with Dominique Charron. What is going to happen tomorrow in the understanding of the functioning of HLA molecules?. Interview by P. Youinou].
    Charron D
    Ann Med Interne (Paris); 1995; 146(1):25-8. PubMed ID: 7741390
    [No Abstract]   [Full Text] [Related]  

  • 2. [An interview with Alan Ebringer. What is going to happen tomorrow concerning HLA-B27 and ankylosing spondylathritis?. Interview by P. Youinou].
    Ebringer A
    Ann Med Interne (Paris); 1994; 145(4):238-40. PubMed ID: 8092648
    [No Abstract]   [Full Text] [Related]  

  • 3. Interview with Robert Schwartz. What is going to happen tomorrow in the field exploring the relationship between viruses and autoimmunity?. Interview by P. Youinou.
    Schwartz R
    Ann Med Interne (Paris); 1992; 143(6):419-20. PubMed ID: 1295397
    [No Abstract]   [Full Text] [Related]  

  • 4. Interview with Ivan M. Roitt. What is going to happen tomorrow as far as glycosylation of IgG is concerned?. Interview by P. Youinou.
    Roitt IM
    Ann Med Interne (Paris); 1993; 144(6):389-91. PubMed ID: 8122821
    [No Abstract]   [Full Text] [Related]  

  • 5. [An interview with Jean-Michel Dayer: what is going to happen tomorrow in the field of cytokines?. Interview by P Youinou].
    Dayer JM
    Ann Med Interne (Paris); 1992; 143(7):445-7. PubMed ID: 1300865
    [No Abstract]   [Full Text] [Related]  

  • 6. Interview with Graham Hughes. What is going to happen tomorrow in the field of anti-phospholipid antibodies?. Interview by P. Youinou.
    Hughes G
    Ann Med Interne (Paris); 1992; 143(6):417-8. PubMed ID: 1295396
    [No Abstract]   [Full Text] [Related]  

  • 7. Interview with Joachim Robert Kalden. What is going to happen tomorrow as far as DNA and anti-DNA antibodies are concerned?. Interview by P. Youinou.
    Kalden JR
    Ann Med Interne (Paris); 1993; 144(7):463-4. PubMed ID: 8141512
    [No Abstract]   [Full Text] [Related]  

  • 8. Interview with Joaquim Coll. What is going to happen tomorrow as far as secondary Sjögren's syndrome is concerned?. Interview by P. Youinou.
    Coll J
    Ann Med Interne (Paris); 1993; 144(4):257-9. PubMed ID: 8368718
    [No Abstract]   [Full Text] [Related]  

  • 9. [An interview with Sylviane Muller by P Youinou. What is going to happen tomorrow in the field of synthetic peptides of autoantigens?].
    Muller S
    Ann Med Interne (Paris); 1993; 144(5):319-22. PubMed ID: 8291840
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interview with Pierre Godeau, President of the Société Nationale Française de Médecine Interne. What is going to happen tomorrow in internal medicine?. Interview by Pierre Youinou].
    Godeau P
    Ann Med Interne (Paris); 1994; 145(1):3-6. PubMed ID: 8192278
    [No Abstract]   [Full Text] [Related]  

  • 11. The HLA molecules: function and role in allorecognition.
    Thorsby E
    Transplant Proc; 1994 Jun; 26(3):1699-701. PubMed ID: 8030091
    [No Abstract]   [Full Text] [Related]  

  • 12. [Human major histocompatibility complex: the HLA system].
    Charron D; Khalil I
    Rev Prat; 1994 Jan; 44(1):20-7. PubMed ID: 8178053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human leucocyte antigen (HLA) system.
    Turner D
    Vox Sang; 2004 Jul; 87 Suppl1():87-90. PubMed ID: 15200613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The HLA gene complex].
    Mayr WR
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):185-91. PubMed ID: 7919906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short history of HLA.
    Thorsby E
    Tissue Antigens; 2009 Aug; 74(2):101-16. PubMed ID: 19523022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1.
    Lajoie J; Hargrove J; Zijenah LS; Humphrey JH; Ward BJ; Roger M
    J Infect Dis; 2006 Jan; 193(2):298-301. PubMed ID: 16362895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of immunogenetics in renal transplantation: HLA-matches and mismatches].
    Müller CA; Müller GA
    Dtsch Med Wochenschr; 2009 Aug; 134(34-35):1692-6. PubMed ID: 19707968
    [No Abstract]   [Full Text] [Related]  

  • 18. [Human histocompatibility HLA system. Considerations in the light of current concepts. II. Immunogenetic function].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(6):509-12. PubMed ID: 11816743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The genetic susceptibility to leprosy in humans].
    Lagrange PH; Abel L
    Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel HLA-G allele (HLA-G*0108) with an alpha-3 domain amino acid change.
    Moscoso J; Serrano-Vela JI; Perez-Saborido B; Moreno E; Arnaiz-Villena A
    Tissue Antigens; 2007 Aug; 70(2):171-3. PubMed ID: 17610427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.